APA (7th ed.) Citation

Zhang, S., Yao, H., Li, H., Su, T., Jiang, S., Wang, H., . . . Yang, X. (2023). Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer. Cellular Oncology (2211-3428), 46(5), 1473. https://doi.org/10.1007/s13402-023-00824-7

Chicago Style (17th ed.) Citation

Zhang, Shan, et al. "Transglutaminases Are Oncogenic Biomarkers in Human Cancers and Therapeutic Targeting of TGM2 Blocks Chemoresistance and Macrophage Infiltration in Pancreatic Cancer." Cellular Oncology (2211-3428) 46, no. 5 (2023): 1473. https://doi.org/10.1007/s13402-023-00824-7.

MLA (9th ed.) Citation

Zhang, Shan, et al. "Transglutaminases Are Oncogenic Biomarkers in Human Cancers and Therapeutic Targeting of TGM2 Blocks Chemoresistance and Macrophage Infiltration in Pancreatic Cancer." Cellular Oncology (2211-3428), vol. 46, no. 5, 2023, p. 1473, https://doi.org/10.1007/s13402-023-00824-7.